Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Total Stockholders Equity : $4,594 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Aspen Pharmacare Holdings Total Stockholders Equity?

Aspen Pharmacare Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $4,594 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Aspen Pharmacare Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was $10.34. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Aspen Pharmacare Holdings's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.42.

Aspen Pharmacare Holdings Total Stockholders Equity Historical Data

The historical data trend for Aspen Pharmacare Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Total Stockholders Equity Chart

Aspen Pharmacare Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

3,716.90

4,039.58

4,716.92

4,485.91

4,600.53

Aspen Pharmacare Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															4,528.24	4,485.91	4,352.43	4,600.53	4,594.05

Aspen Pharmacare Holdings (OTCPK:APNHY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Aspen Pharmacare Holdings's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4594.049	-	0)	/	444.300
	=	10.34

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Aspen Pharmacare Holdings's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(622.504	+	1315.798)	/	4594.049
	=	0.42

Aspen Pharmacare Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

APN:South Africa

Address

Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF

Website

https://www.aspenpharma.com

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Aspiring for Aspen Pharmacare Holdings Ltd's Dividend: A Comprehensive Analysis

By GuruFocus Research • 09-21-2023

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos • 03-17-2019